% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • bosiedude bosiedude Dec 27, 2012 1:08 PM Flag


    I've followed INFI due to their hsp90 inhibitor, which is the best viable competitor to ganetespib. However, I didnt invest in INFI because I think ours is better, as theirs is more chemically related to some other failed ones. So I didnt invest in Infinity.
    But I'm kicking myself because I've been asleep at the wheel. Their other big drug (anti-inflammatory, anti-cancer) could be a gigantic blockbuster. Their hsp90 inhibitor is just possible icing on the cake

0.3430.000(0.00%)Jul 22 3:59 PMEDT